Acute angle closure following periorbital botulinum toxin injection in a patient with retinitis pigmentosa
نویسندگان
چکیده
منابع مشابه
Acute angle closure following periorbital botulinum toxin injection in a patient with retinitis pigmentosa
A 50-year-old female presented with bilateral retinitis pigmentosa (RP) and acute angle closure (AAC) with fixed mid-dilated pupil and high intraocular pressure (IOP) in the left eye following left side periorbital botulinum toxin A injection for blepharospasm. Glaucomatous optic neuropathy and retinal nerve fiber layer defect were observed in the affected eye using optical coherence tomography...
متن کاملAcute angle-closure glaucoma following botulinum toxin injection for blepharospasm.
Botulinum toxin inhibits acetylcholine release and therefore could cause mydriasis. We report a case of acute angle-closure glaucoma which occurred shortly after a series of injections of botulinum toxin round the eyelids for blepharospasm.
متن کاملIncreased Risk of Acute Angle Closure in Retinitis Pigmentosa: A Population-Based Case-Control Study
PURPOSE To investigate the association between retinitis pigmentosa (RP) and acute angle closure during a 15-year follow-up period. METHODS Using the Taiwan Longitudinal Health Insurance Database 2000, we identified 382 RP patients based on the diagnostic code of RP (International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) 362.74) made during 1996-2010, excludi...
متن کاملbotulinum toxin-a injection in acute sixth nerve palsy
purpose: to evaluate the effect of botulinum toxin-a as an alternate to surgery in acute complete sixth nerve palsy and to shorten the recovery period. methods: thirty patients with acute complete sixth nerve palsy received 1-10 units of botulinum toxin-a (dysport) injection in the medial rectus muscle within one month from the onset of palsy. toxin was injected directly into the muscle belly u...
متن کاملNeuralgic amyotrophy following botulinum toxin injection.
Botulinum toxin (BT) is a polypeptidic neurotoxin produced by Clostridium botulinum that is widely used in medicine [1]. The U.S. Food and Drug Administration (FDA) approved BT type A injection use for the treatment of cervical dystonia, blepharospasm, primary axillary hyperhydrosis and cosmetic use for glabellar lines, and it is also widely used to treat spasticity, siallorhea, chronic tension...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Taiwan Journal of Ophthalmology
سال: 2017
ISSN: 2211-5056
DOI: 10.4103/tjo.tjo_41_17